Actelion Ltd.
Gewerbestrasse 16
Allschwil
CH - 4123
Tel: 41-61-487-4545
Fax: 41-61-487-4507
Website: http://www.actelion.com/
139 articles about Actelion Ltd.
-
Actelion Ltd. Extends Partnership with Invida Pharmaceutical Holdings to Market Tracleer in Key Asian Markets
3/26/2010
-
FDA Panel Backs Use Of Actelion Ltd.'s (JOBS) Zavesca For Rare Genetic Disorder
1/13/2010
-
US FDA Questions Actelion Ltd. (JOBS) Rare Disease Drug Data
1/8/2010
-
Actelion Ltd. (JOBS) Sees $80 Million Hit From Ruling
12/22/2009
-
Actelion Ltd. (JOBS) Almorexant Meets Target; Flags Safety Woes
12/21/2009
-
Actelion Ltd. (JOBS) Latest Casualty as Roche (JOBS) Trims Portfolio; Roche Drops Actelion Study in Favor of Own Drug
12/9/2009
-
FDA to Review Actelion Ltd.'s (JOBS) Zavesca for Additional Use
11/19/2009
-
Actelion Ltd.'s (JOBS) Tracleer Gets US Approval for Wider Use
8/10/2009
-
US Regulators Need More Info on Actelion Ltd. Drug
3/2/2009
-
GeneraMedix Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd.
2/23/2009
-
Actelion Ltd. CEO Says New Use May Double Tracleer Sales
8/26/2008
-
Actelion Ltd. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
6/20/2008
-
Actelion Ltd. Swings to Profit, Key Drug Tracleer Disappoints
4/22/2008
-
Actelion Ltd. Reports Total Net Revenues for 2007
1/21/2008
-
Process Innovation Vision Award Honors Anoto Group AB and Actelion Ltd.
12/19/2007
-
Actelion Ltd. Provides Update On Bosentan in Metastatic Melanoma
12/17/2007
-
Actelion Ltd./Merck & Co., Inc. Renin Alliance Achieves Fourth Milestone -- Dosing in Phase II Initiated -- Actelion Receives USD10 Million
12/5/2007
-
Actelion Ltd.: Pivlaz (Clazosentan) Phase III Study Initiated to Demonstrate Prevention of Vasospasm-Related Morbidity and All-Cause Mortality After Aneurysmal Subarachnoid Hemorrhage
11/12/2007
-
Actelion Ltd. Miglustat (Zavesca) Receives Negative Opinion From the European Committee For Medicinal Products For Human Use For Extension of Indication For Niemann Pick Type C
10/19/2007
-
Actelion Ltd. Announces Half Year Financial Results 2007
7/19/2007